Literature DB >> 15725781

Death due to Ehlers-Danlos syndrome type IV.

Joseph A Prahlow1, Scott A Wagner.   

Abstract

Ehlers-Danlos syndrome (EDS) represents a group of collagen connective tissue disorders characterized by joint laxity, easy bruising, and various skin manifestations. Persons with type IV EDS are at risk for gastrointestinal, uterine, and arterial rupture. Mutations in the COL3A1 gene that encodes for type III procollagen underlie the pathologic abnormalities. Forensic pathologists must be aware of this rare, autosomal-dominant connective tissue disorder. Postmortem diagnosis is possible but requires specialized testing (fibroblast culture and subsequent biochemical assays, with or without molecular studies). When the condition is diagnosed or suspected at autopsy, it is important for forensic pathologists to notify family members of this potentially lethal disorder. Three cases of type IV EDS diagnosed by forensic pathologists are presented, followed by a discussion of the disorder.

Entities:  

Mesh:

Year:  2005        PMID: 15725781     DOI: 10.1097/01.paf.0000153997.06338.4b

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  4 in total

1.  Common iliac artery aneurysm and spontaneous dissection with contralateral iatrogenic common iliac artery dissection in classic ehlers-danlos syndrome.

Authors:  Sachin Mehta; Shweta U Dhar; Yochai Birnbaum
Journal:  Int J Angiol       Date:  2012-09

Review 2.  Ehlers-Danlos syndrome (EDS) type IV: review of the literature.

Authors:  Cristiano Macabu Badauy; Sabrina S Gomes; Manoel Sant'Ana Filho; José Artur Bogo Chies
Journal:  Clin Oral Investig       Date:  2007-01-13       Impact factor: 3.573

Review 3.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

4.  Ehlers-danlos syndrome in orthopaedics: etiology, diagnosis, and treatment implications.

Authors:  Eric D Shirley; Marlene Demaio; Joanne Bodurtha
Journal:  Sports Health       Date:  2012-09       Impact factor: 3.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.